Home > News > Microstructural Changes in Central Serous Chorioretinopathy Documented by Spectral-domain Optical Coherence Tomography
Retina/Vitreous
Read Time: 6 mins

Microstructural Changes in Central Serous Chorioretinopathy Documented by Spectral-domain Optical Coherence Tomography

Published Online: January 22nd 2014 European Ophthalmic Review, 2013;7(2):98–101 DOI: http://doi.org/10.17925/EOR.2013.07.02.98
Authors: Dominik Odrobina, Piotr Gozdek, Mariusz Maroszyński, Iwona Laudańska-Olszewska
Quick Links:
Abstract
Article
Article Information
Abstract:
Overview

Central serous chorioretinopathy (CSC) was first described more than 140 years ago. Due to the rapid development in modern imaging methods, better understanding of changes occurring in the retina in CSC is possible. Spectral-domain optical coherence tomography (SDOCT) has increased our ability to study this disease, especially microstructural changes during active phase and after resolution of CSC. SD-OCT enables a highly detailed in vivo evaluation of the individual retinal layers especially external limiting membrane (ELM), the inner and outer segments of photoreceptors and changes in retinal pigment epithelium (RPE), which are the most essential and important in described disease. It allows us better understand pathogenesis of CSC.

Keywords

Spectral-domain optical coherence tomography, central serous chorioretinopathy, photoreceptor inner and outer segments, retinal pigment epithelium, visual acuity

Article:

Central serous chorioretinopathy (CSC) is a disease characterised by idiopathic serous neurosensory retinal detachment secondary to leakage from retinal pigment epithelium (RPE).1 This disease was first recognised in 1866 by Albrecht von Graefe.2

Due to the rapid development of modern imaging methods, better understanding of changes occurring in the retina in CSC is possible. Also, their influence on functional results in active CSC and after resolution of subretinal fluid in CSC can be presented. Stratus optical coherence tomography (OCT) (Carl Zeiss Meditec, Inc., Dublin, California, US) shows many changes appearing in retinal layers, especially in the photoreceptor layer in the area of the serous detachments in CSC.3,4 However, the details of the retinal layers are unclear because of the 10 μm axial resolution limitation.

Spectral-domain OCT (SD-OCT) instruments offer two main advantages compared with the previous traditional time-domain (TD) OCT: higher speed and improved resolution (~3–7 μm). Multiple B-scan averaging technology permits the production of detailed, speckle-noise-reduced images of all the retinal layers. SD-OCT’s superior resolution allows highly detailed in vivo evaluation of the individual retinal layers, especially the external limiting membrane (ELM), the inner and outer segments (IS/OS) of photoreceptors and changes in RPE.5,6

Several papers describing OCT findings in eyes with CSC have been published. Various abnormalities were described. OCT presents foveal destoration, cystic and macular changes, RPE detachment (PED) and small bulges protruding from RPE.4,7,8 Some of the authors thought that part of these abnormalities can be artefacts due to the limited axial resolution of the OCT.

Retinal Thickness
Using TD-OCT, it was difficult to measure each retinal layer in acute phase of CSC, thus these studies provided total retinal thickness.

Different thickening of the retina during the active phase of CSC has been presented by various authors. Some claim that the thickness of the retina in CSC is thinner than in healthy eyes.9 In our patients [unpublished data], mean foveal retinal thickness during the acute phase of CSC was similar to that of healthy eyes, and the results were similar among other authors.10,11 In patients with chronic CSC the thickness of the retina is slightly reduced in comparison with healthy eyes [unpublished data].Some authors thought that part of these abnormalities can be artefacts, because of the limited axial resolution of the OCT. Sun et al. also stated that the height of the detached retina at the fovea was similar to that of RRD.12 High-speed, high-resolution OCT has expanded our ability to study these diseases, especially microstructural changes during the active phase and after the resolution of CSC.

Photoreceptors Changes
Changes in photoreceptors and RPE layers are the most essential and important changes in described disease. Matsumoto et al. analysed morphological changes in the photoreceptor segment of the detached retina in CSC.10 The authors showed that outer nuclear layer (ONL) thickness (the measurement between the internal limiting membrane [ILM] and the ELM) in the central fovea was approximately 75 μm in CSC, and was statistically significant shorter than the average thickness of 135 μm in healthy eyes. ONL thickness correlated weakly with age, best corrected visual acuity (BCVA) and the duration of symptoms. Matsumoto also presented the elongation of photoreceptor OS. The average thickness of the longest outer photoreceptor segment was 90 μm in CSC and was significantly longer than that of healthy subjects with a typical value of 60 μm. OS was not at all or was weakly correlated with age, BCVA and duration of symptoms. Similar to Matsumoto et al., we stated that during the active process extension of the photoreceptor OS was taking place (see Figure 1) [unpublished data]. These results are in opposition to the studies of Yu et al.13 The ONL thickness in CSC is not different from that of healthy eyes and measures 97 μm on average.The authors also did not find the difference between the length of photoreceptors in patients with CSC and in healthy eyes.

Another interesting publication concerning ONL is one by Maruko et al.14 The authors compared changes in the outer layer of the detached retina in patients with rhegmatogenous retinal detachment (RRD) and CSC. According to their study, ONL was significantly thicker in patients with retinal detachment than in patients with CSC. Moreover, the authors noticed that BCVA after reattachment was correlated with the thickness of the ONL in patients with detachment of the retina. These results stood in opposition to those of the CSC group where no correlation was noted between retinal morphological changes and visual function.

The development of SD-OCT technology in recent years resulted in the observation that persistent leakage and subretinal fluid may cause RPE alterations and photoreceptor changes, which may correlate with a worsening of VA.10,15 Ooto et al. compared pathological changes in photoreceptors in eyes with resolved CSC seen on high-resolution images obtained from adaptive optics scanning laser ophthalmoscopy (AO SLO) with VA and findings on SD-OCT.15 The study included 54 eyes of 38 patients with resolved CSC and 20 healthy eyes. In eyes with disruption in the photoreceptor IS/OS visible in SD-OCT, the mean cone density was significantly lower than in eyes with intact IS/OS or the intermediate line. These findings correlate with VA loss. Ojima et al. also analysed OS of foveal photoreceptors after resolution of CSC16. They showed in 71.6 % of eyes that IS/OS were clearly detectable in SD-OCT with good VA . In 12 % of the eyes, they noted recovery of the IS/OS foveal line, which was connected with VA recovery. In some eyes no restoration of outer segments of foveal photoreceptors was detected and the prognosis of visual recovery remained poor. In conclusion of the cited examinations we can state that defects in the photoreceptor layer correlated with VA (see Figure 2). Analysis of these results is supported by other authors, who state that if subfoveal fluid persisted more than 4 months foveal atrophy may occur anytime,9 and degenerative changes often develop in the macula in CSC cases lasting longer than 6 months.16 These changes correlate with the changes in VA .

SD-OCT reveals also that ONL and photoreceptor inner segments were thicker in healthy eyes than in eyes with CSC and polypoidal choroidal vasculopathy (PCV).17 However, Ooto stated that the photoreceptor OS were thinner in eyes with PCV than in healthy eyes or in eyes with CSC. These findings make SD-OCT helpful in differentiating PCV from CSC.

Another option available in SD-OCT is autofluorescence examination. It is helpful in the evaluation of changes occurring in the retina during the active phase of CSC (see Figure 3). It can give us additional answers about the progression and lifespan of the active process. In the authors’ opinion it was not possible to evaluate any irreversible changes that had already occurred in the photoreceptor layer during active phase of CSC [unpublished data]. Elongation of the outer segments of photoreceptors, which is observed in CSC, may be due to a lack of photoreceptor phagocytosis by the RPE.10 The duration of the elongation of this layer may affect the simultaneous initiation of photoreceptor apoptosis. The results are also supported by Spaide,18 who analysed the autofluorescence of CSC. Spaide hypothesised that an increased autofluorescence may represent photoreceptor outer segments phagocytised by the RPE.

Retinal Pigment Epithelium Changes
Various abnormalities in RPE have been described in eyes with CSC.13,19 Gup et al. proved the presence of PED in only 11.8 % of eyes with idiopathic CSC and RPE bumps in 94 % of eyes. Yu et al. showed PED in 72.2 % of eyes and a small bulge of RPE in only 34.5 % of eyes. The first to find small bulges protruding from RPE was Drexler et al., but they considered them to be PED or artefacts.7 In another study, Montero et al. consider them to be RPE protrusions or a thickening.4 Fujimoto et al. called these RPE abnormalities protruding or irregular RPE layer.20 In an OCT-ophtahlmoscope examination, Kon et al. found subretinal and intraretinal bright dots.21 Fujimoto et al. also found fibrinous exudates in the subretinal space visible in the SD-OCT in nearly half of examined eyes in the leakage or above the leakage sites.20 Kon et al. suggested that intraretinal preciptates in eyes with CSC may result from accumulation of proteins or macrophages with the phagocytised photoreceptor OS.21 The subretinal precipitates may also be photoreceptor OS phagocytised by the RPE. In this way it is sometimes difficult to state whether these changes are from RPE abnormalities or if they are subretinal precipitates from photoreceptors OS.

Leakage Site in Central Serous Chorioretinopathy
In spite of confirmed knowledge about CSC, the pathogenesis of this disease remains questionable. Over the years the hypothesis about the leakage site has changed: from single damage, interrupture of RPE22 to hypersecretion of RPE23 and leakage from the pigment epithelium detachment (see Figure 4). Fujimoto et al. analysed the leakage site in the SD-OCT and found RPE abnormalities in 22 (96 %) of the leakage sites. In 14 cases it was PED and a protruding or irregular RPE layer in eight. They also showed RPE defects at the edge or within PED in 22 % of the leakage sites. In the eyes with residual subretinal fluid, the smooth posterior surface of the detached retina became granulated.20 Despite much new information about microstructural changes in the leakage sites, our questions remain unanswered.

Choroidal Changes
Indocyanine green angiographic findings strongly suggest that the principle mechanism underlying CSC involves choroidal vascular changes. Using the enhanced depth imaging SD-OCT (EDI OCT) technique, several authors have showed that the subfoveal choroid in symptomatic eyes was significantly thicker than that in normal or fellow eye.25,26

Jirarattanasopa et al. analysed the relationship between macular choroidal thickness measured by high-penetrating swept-source OCT (SS-OCT) and fluorescein (FA) and indocyanine green angiographic (IA) findings. The authors showed that choroid was thicker in all subtypes of CSC. They also showed that mean choroidal thickness was significantly greater in areas with leakage visible on FA and in areas with choroidal vascular hyperpermeability on IA. These findings suggested that changes in the choroid may give us an answer about the pathogenesis of the disease.27

In conclusion, the latest publication gives us more information about microstructural changes in the retina occurring in CSC, especially in the IS/OS of photoreceptors and RPE. It allows us to better understand the pathogenesis of this disease. The development of SD-OCT technology in recent years has resulted in various authors noting that persistent leakage and subretinal fluid may cause RPE alterations and photoreceptor changes, which may correlate with a worsening of VA . Despite the significant progress that has been made in the last few years in OCT technology, we still do not have sufficient knowledge about the pathogenesis of CSC.

Article Information:
Disclosure

The authors have no conflicts of interest to declare.

Correspondence

Dominik Odrobina, Ophthalmology Clinic Boni Fratres Lodziensis, ul. Hippiczna 36 m 2, 94–049 Lodz, Poland. E: odro@vp.pl
An erratum to this article can be found below.

Received

2013-06-26T00:00:00

References

  1. Gass JD, Pathogenesis of disciform detachment of the neuroepithelium: II. Idiopathic central serous choroidopathy, Am J Ophthalmol, 1967;63:587–615.
  2. von Graefe A, Ueber central recidivierende retinitis, Graefes Arch Clin Exp Ophthalmol, 1866;12:211–15.
  3. P iccolino FC, de la Longrais RR, Ravera G, et al., The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy, Am J Ophthalmol, 2005;139:87–99.
  4. M ontero JA, Ruiz-Moreno JM, Optical coherence tomography characterization of idiopathic central serous chorioretinopathy, Br J Ophthalomol, 2005;89:562–64.
  5. W ojtkowski M, Bajraszewski T, Gorczynska I, et al., Ophthalmic imaging by spectral optical coherence tomography, Am J of Ophthalmol, 2004;138(3):412–19.
  6. W ojtkowski M, Srinivasan V, Fujimoto JG, et al., Threedimensional retinal imaging with high-speed ultrahighresolution optical coherence tomography, Ophthalmology, 2005;112(10):1734–46.
  7. Drexler W, Sattamann H, Hermann B, et al., Enhanced visualization of macular pathology with the use of ultrahighresolution optical coherence tomography, Arch Ophthalmol, 2003;121:695–706.
  8. I ida T, Kishi S, Hagimura N, Shimizu K, Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy, Retina, 1999;19(6):508–12.
  9. W ang MS, Sander B, Larsen M, Retinal atrophy in idiopathic serous chorioretinopathy, Am J Ophthalmol, 2002;133:787–93.
  10. M atsumoto H, Kishi S, Otani T, Sato T, Elongation of photoreceptor outer segment in central serous chorioretinopathy, Am J Ophthalmol, 2008;145:162–8.
  11. I ida T, Hagimura N, Sato T, et al., Evaluation of central serous chorioretinopathy with optical coherence tomography, Am J Ophthalmol, 2000;129:16–20.
  12. Sun Young Lee, Soo Geun Joo, June-Gone Kim, et al., Optical Coherence Tomography Evaluation of Detached Macula from Rhegmatogenous Retinal Detachment and Central Serous Chorioretinopathy, Am J Ophthalmol, 2008;145:1071–6.
  13. Yu H, Xia GY, Gao MH, et al., Morphologic changes in acute central serous chorioretinopathy evaluated by spectral domain optical coherence tomography, Zhonghua Yan Ke Za Zhi, 2011;47(6):508–15.
  14. M aruko I, Iida T, Sekiryu T, Saito M, Morphologic changes in the outer layer of the detached retina in rhegmatogenous retinal detachment and central serous chorioretinopathy Am J Ophthalmol, 2009;147(3):489–94.
  15. O oto S, Hangai M, Sakamoto A, et al., High-resolution imaging of resolved central serous chorioretinopathy using adaptive optics scanning laser ophthalmoscopy, Ophthalmology, 2010;117(9):1800–1809.
  16. O jima Y, Tsujikawa A, Yamashiro K, et al., Restoration of outer segments of foveal photoreceptors after resolution of central serous chorioretinopathy, Jpn J Ophthalmol, 2010;54(1):55–60.
  17. O oto S, Tsujikawa A, Mori S, et al., Thickness of photoreceptor layers in polypoidal choroidal vasculopathy and central serous chorioretinopathy, Graefes Arch Clin Exp Ophthalmol, 2010;248(8):1077–86.
  18. Spaide RF, Klancnik JM Jr, Fundus autofluorescence and central serous chorioretinopathy, Ophthalmology, 2005;112:825–83
  19. Gupta P, Gupta V, Dogra MR, et al., Morphological changes in the retinal pigment epithelium on spectral-domain OCT in the unaffected eyes with idiopathic central serous chorioretinopathy, Int Ophthalmol, 2010;30(2):175–81.
  20. Fujimoto H, Gomi F, Wakabayashi T, et al., Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography, Ophthalmology, 2008;115(9):1494–500.
  21. Kon Y, Iida T, Maruko I, Saito M, The optical coherence tomography-ophthalmoscope for examination of central serous chorioretinopathy with precipitates, Retina, 2008;28(6):864–9.
  22. L euenberger A, Gasche A, Light coagulation for central serous retinopathy, Ophthalmologica, 1972;165(3–4):366–72.
  23. Spitznas M, Pathogenesis of central serous retinopathy: a new working hypothesis, Graefes Arch Clin Exp Ophthalmol, 1986;224(4):321–4.
  24. M armor MF, New hypotheses on the pathogenesis and treatment of serous retinal detachment, Graefes Arch Clin Exp Ophthalmol, 1988;226(6):548–52.
  25. M aruko I, Iida T, Sugano Y, et al., Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy, Retina, 2011;31(8):1603–8.
  26. I mamura Y, Fujiwara T, Margolis R, Spaide RF, Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy, Retina, 2009;29(10):1469–73.
  27. Jirarattanasopa P, Ooto S, Tsujikawa A, et al., Assessment of Macular Choroidal Thickness by Optical Coherence Tomography and Angiographic Changes in Central Serous Chorioretinopathy, Ophthalmology, 2012;119(8):1666–78.

Further Resources

Share this Article
Related Content In Retina/Vitreous
  • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72